QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
(State or other jurisdiction of incorporation or organization) |
(Commission File Number) |
(IRS Employer Identification No.) |
(Address Of Principal Executive Offices) |
(Zip Code) |
Title of each class |
Trading Symbol(s) |
Name of each exchange on which registered | ||
share, $0.0001 par value, and one-third of one redeemable warrant |
||||
Large accelerated filer | ☐ | Accelerated filer | ☐ | |||
Non-accelerated filer |
☒ | Smaller reporting company | ||||
Emerging growth company |
• |
Part I - Item 1. Financial Statements. |
• |
Part I - Item 4. Controls and Procedures. |
• |
Part II - Item 6. Exhibits. |
Page |
||||||
Item 1. |
1 |
|||||
1 |
||||||
2 |
||||||
3 |
||||||
4 |
||||||
5 |
||||||
Item 2. |
17 |
|||||
Item 3. |
21 |
|||||
Item 4. |
21 |
|||||
Item 1. |
21 |
|||||
Item 1A. |
22 |
|||||
Item 2. |
22 |
|||||
Item 3. |
22 |
|||||
Item 4. |
22 |
|||||
Item 5. |
22 |
|||||
Item 6. |
22 |
|||||
23 |
Item 1. |
Financial Statements |
September 30, 2021 |
December 31, 2020 |
|||||||
(Unaudited) |
||||||||
ASSETS |
||||||||
Current Assets: |
||||||||
Cash |
$ | $ | ||||||
Prepaid expenses |
||||||||
Total current assets |
||||||||
Investments held in Trust Account |
||||||||
Total assets |
$ |
$ |
||||||
LIABILITIES AND SHAREHOLDERS’ DEFICIT |
||||||||
Current liabilities: |
||||||||
Accounts payable |
$ | $ | ||||||
Accrued expenses |
||||||||
Due to related party |
||||||||
Total current liabilities |
||||||||
Deferred underwriting commissions |
||||||||
Derivative warrant liabilities |
||||||||
Total liabilities |
||||||||
Commitments and Contingencies (Note 6) |
||||||||
Class A ordinary shares subject to possible redemption, |
||||||||
Shareholders’ Deficit |
||||||||
Preference shares, $ |
||||||||
Class A ordinary shares, $ |
||||||||
Class B ordinary shares, $ |
||||||||
Additional paid-in capital |
||||||||
Accumulated deficit |
( |
) | ( |
) | ||||
Total shareholders’ deficit |
( |
) | ( |
) | ||||
Total Liabilities and Shareholders’ Deficit |
$ |
$ |
||||||
Three Months Ended September 30, 2021 |
Nine Months Ended September 30, 2021 |
For The Period From September 2, 2020 (inception) through September 30, 2020 |
||||||||||
General and administrative expenses |
$ | $ | $ | |||||||||
Administrative expenses - related party |
||||||||||||
Loss from operations |
( |
) | ( |
) | ( |
) | ||||||
Interest income from investments held in Trust Account |
||||||||||||
Change in fair value of derivative warrant liabilities |
||||||||||||
Net Income (Loss) |
$ |
$ |
$ |
( |
) | |||||||
Weighted average shares outstanding of Class A ordinary shares |
||||||||||||
Basic and diluted net income (loss) per share, Class A ordinary shares |
$ |
$ |
$ |
|||||||||
Weighted average shares outstanding of Class B ordinary shares |
||||||||||||
Basic and diluted net income per share, Class B ordinary shares |
$ |
$ |
$ |
|||||||||
Ordinary Shares |
||||||||||||||||||||
Class B |
||||||||||||||||||||
Shares |
Amount |
Additional Paid- In Capital |
Accumulated Deficit |
Total Shareholders’ Deficit |
||||||||||||||||
Balance - January 1, 2021 |
$ |
$ |
$ |
( |
) |
$ |
( |
) | ||||||||||||
Net income |
— | — | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Balance - March 31, 2021 (unaudited) |
$ |
$ |
$ |
( |
) |
$ |
( |
) | ||||||||||||
Net loss |
— | — | ( |
) | ( |
) | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Balance - June 30, 2021 (unaudited) |
$ |
$ |
$ |
( |
) |
$ |
( |
) | ||||||||||||
Net income |
— | — | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Balance - September 30, 2021 (unaudited) |
$ |
$ |
$ |
( |
) |
$ |
( |
) | ||||||||||||
|
|
|
|
|
|
|
|
|
|
Ordinary Shares |
||||||||||||||||||||
Class B |
||||||||||||||||||||
Shares |
Amount |
Additional In Capital |
Accumulated Deficit |
Total Shareholders’ Deficit |
||||||||||||||||
Balance as of September 3, 2020 (inception) |
$ |
$ |
$ |
$ |
||||||||||||||||
Issuance of ordinary shares to Sponsor |
— | — | ||||||||||||||||||
Net loss |
— | — | ( |
) | ( |
) | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Balance as of September 30, 2020 (unaudited) |
$ |
$ |
$ |
( |
) |
$ |
( |
) | ||||||||||||
|
|
|
|
|
|
|
|
|
|
Nine Months Ended September 30, 2021 |
For The Period From September 2, 2020 (inception) through September 30, 2020 |
|||||||
Cash Flows from Operating Activities: |
||||||||
Net income (loss) |
$ | $ | ( |
) | ||||
Adjustments to reconcile net income (loss) to net cash used in operating activities: |
||||||||
Change in fair value of derivative warrant liabilities |
( |
) | — | |||||
Interest income from investments held in Trust Account |
( |
) | — | |||||
General and administrative expenses paid by Sponsor in exchange for issuance of Class B ordinary shares |
— | |||||||
Changes in operating assets and liabilities: |
||||||||
Prepaid expenses |
— | |||||||
Accounts payable |
— | |||||||
Accrued expenses |
— | |||||||
|
|
|
|
|||||
Net cash used in operating activities |
( |
) | ||||||
|
|
|
|
|||||
Cash Flows from Financing Activities: |
||||||||
Advances from related party |
— | |||||||
|
|
|
|
|||||
Net cash provided by financing activities |
— | |||||||
|
|
|
|
|||||
Net decrease in cash |
( |
) | — | |||||
Cash - beginning of period |
— | |||||||
|
|
|
|
|||||
Cash - end of period |
$ | $ | — | |||||
|
|
|
|
|||||
Supplemental disclosure of noncash investing and financing activities: |
||||||||
Deferred offering costs included in accounts payable |
$ | $ | ||||||
|
|
|
|
|||||
Deferred offering costs included in accrued expenses |
$ | $ | ||||||
|
|
|
|
|||||
Deferred offering costs paid through promissory note — related party |
$ | $ | ||||||
|
|
|
|
|||||
Deferred offering costs paid through the issuance of ordinary shares to Sponsor |
$ | $ | ||||||
|
|
|
|
As of March 31, 2021 |
||||||||||||
Condensed Balance Sheet |
As Previously Reported |
Restatement Adjustment |
As Restated |
|||||||||
Class A ordinary shares subject to possible redemption |
$ |
$ |
$ |
|||||||||
Shareholders’ Equity |
||||||||||||
Class A ordinary shares, $ |
$ |
$ |
( |
) | $ |
— | ||||||
Class B ordinary shares, $ |
$ |
$ |
— | $ |
||||||||
Additional paid-in capital |
$ |
$ |
( |
) | $ |
— | ||||||
Accumulated deficit |
$ |
( |
) | $ |
( |
) | $ |
( |
) |
Three Months Ended March 31, 2021 |
||||||||||||
Condensed Statement of Operations |
As Previously Reported |
Restatement Adjustment |
As Restated |
|||||||||
Weighted average shares outstanding of Class A ordinary shares |
— |
|||||||||||
Basic and diluted net income per ordinary share, Class A |
$ |
— |
$ |
$ |
||||||||
Weighted average shares outstanding of Class B ordinary shares |
— |
|||||||||||
Basic and diluted net loss per ordinary share, Class B |
$ |
$ |
( |
) |
$ |
As of June 30, 2021 |
||||||||||||
Condensed Balance Sheet |
As Previously Reported |
Restatement Adjustment |
As Restated |
|||||||||
Class A ordinary shares subject to possible redemption |
$ |
$ |
$ |
|||||||||
Shareholders’ equity (deficit) |
||||||||||||
Class A ordinary shares, $ |
$ |
$ |
( |
) |
$ |
— |
||||||
Class B ordinary shares, $ |
$ |
$ |
— |
$ |
||||||||
Additional paid-in capital |
$ |
$ |
( |
) |
$ |
— |
||||||
Accumulated deficit |
$ |
( |
) |
$ |
( |
) |
$ |
( |
) |
Three Months Ended June 30, 2021 |
||||||||||||
Condensed Statement of Operations |
As Previously Reported |
Restatement Adjustment |
As Restated |
|||||||||
Weighted average shares outstanding of Class A ordinary shares |
— |
|||||||||||
Basic and diluted net loss per ordinary share, Class A |
$ |
— |
$ |
( |
) |
$ |
( |
) | ||||
Weighted average shares outstanding of Class B ordinary shares |
— |
|||||||||||
Basic and diluted net loss per ordinary share, Class B |
$ |
( |
) |
$ |
$ |
( |
) |
Six Months Ended June 30, 2021 |
||||||||||||
Condensed Statement of Operations |
As Previously Reported |
Restatement Adjustment |
As Restated |
|||||||||
Weighted average shares outstanding of Class A ordinary shares |
— |
|||||||||||
Basic and diluted net income per ordinary share, Class A |
$ |
— |
$ |
$ |
||||||||
Weighted average shares outstanding of Class B ordinary shares |
— |
|||||||||||
Basic and diluted net loss per ordinary share, Class B |
$ |
$ |
( |
) |
$ |
• |
Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; |
• |
Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and |
• |
Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. |
• | in whole and not in part; |
• | at a price of $ |
• | upon a minimum of 30 days’ prior written notice of redemption; and |
• | if, and only if, the last reported sale price (the “closing price”) of 30-trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders. |
• | in whole and not in part; |
• | at $ |
• | if, and only if, the closing price of the Company’s Class A ordinary shares equals or exceeds $ 30-trading day period ending three trading days before the Company sends the notice of redemption to the warrant holders; and |
• | the closing price of the Class A ordinary shares for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders is less than $ |
Description |
Quoted Prices in Active Markets (Level 1) |
Significant Other Observable Inputs (Level 2) |
Significant Other Unobservable Inputs (Level 3) |
|||||||||
Assets: |
||||||||||||
Investments held in Trust Account |
$ | $ | — | $ | — | |||||||
Liabilities: |
||||||||||||
Derivative warrant liabilities - Public |
$ | $ | — | $ | — | |||||||
Derivative warrant liabilities - Private |
$ | — | $ | $ | — |
Description |
Quoted Prices in Active Markets (Level 1) |
Significant Other Observable Inputs (Level 2) |
Significant Other Unobservable Inputs (Level 3) |
|||||||||
Assets: |
||||||||||||
Investments held in Trust Account |
$ | $ | — | $ | — | |||||||
Liabilities: |
||||||||||||
Derivative warrant liabilities - Public |
$ | $ | — | $ | — | |||||||
Derivative warrant liabilities - Private |
$ | — | $ | $ | — |
Item 2. |
Management’s Discussion and Analysis of Financial Condition and Results of Operations. |
Item 3. |
Quantitative and Qualitative Disclosures About Market Risk |
Item 4. |
Controls and Procedures |
Item 1. |
Legal Proceedings |
Item 1A. |
Risk Factors |
Item 2. |
Unregistered Sales of Equity Securities and Use of Proceeds. |
Item 3. |
Defaults upon Senior Securities |
Item 4. |
Mine Safety Disclosures. |
Item 5. |
Other Information. |
Item 6. |
Exhibits. |
* |
These certifications are furnished to the SEC pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and are deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall they be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing. |
Dated: December 29, 2021 | H.I.G. ACQUISITION CORP. | |||||
By: | /s/ Timur Akazhanov | |||||
Name: Timur Akazhanov | ||||||
Title: | Chief Financial Officer |